These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30110706)

  • 1. Effect of Growth Hormone Therapy on Height Velocity in Korean Children with Idiopathic Short Stature: A Phase III Randomised Controlled Trial.
    Chung WY; Yoo HW; Hwang JS; Ko CW; Kim HS; Jin DK; Lee KH; Han HS; Paranchothy P; Suh BK
    Horm Res Paediatr; 2018; 90(1):44-53. PubMed ID: 30110706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature.
    Lampit M; Hochberg Z
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3573-7. PubMed ID: 12161476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial.
    Kim J; Suh BK; Ko CW; Lee KH; Shin CH; Hwang JS; Kim HS; Chung WY; Kim CJ; Han HS; Kwon NY; Cho SY; Yoo HW; Jin DK
    J Endocrinol Invest; 2018 Apr; 41(4):475-483. PubMed ID: 29103133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature.
    Barton JS; Gardineri HM; Cullen S; Hindmarsh PC; Brook CG; Preece MA
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):619-26. PubMed ID: 7634503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-Weekly Administration of Sustained-Release Growth Hormone in Korean Prepubertal Children with Idiopathic Short Stature: A Randomized, Controlled Phase II Study.
    Hwang JS; Lee HS; Lee KH; Yoo HW; Lee DY; Suh BK; Ko CW; Chung WY; Jin DK; Shin CH; Han HS; Han S; Kim HS
    Horm Res Paediatr; 2018; 90(1):54-63. PubMed ID: 29925064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised study of the effect of two doses of biosynthetic human growth hormone on final height of children with familial short stature.
    Elder CJ; Barton JS; Brook CG; Preece MA; Dattani MT; Hindmarsh PC
    Horm Res; 2008; 70(2):89-92. PubMed ID: 18547955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A randomized, multicentric, investigator-blind, phase 3 trial.
    Czepielewski MA; Garret Q; Vencio SAC; Rassi N; Felicio JS; Faria MS; Senn CCP; Bronstein MD; Cerqueira MJAG; Neves ACL; Sgarbi JA; Spinola-Castro AM; Cunha MPR; Bandeira F; Toffoletto O; Afiune J; Baradelli R; Rodrigues DG; Scharf M
    Growth Horm IGF Res; 2019; 48-49():29-35. PubMed ID: 31493626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-month, prospective, longitudinal, open-label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement.
    Kennedy MJ; Davis DA; Smith N; Gaedigk A; Pearce RE; Kearns GL
    Clin Ther; 2008 Sep; 30(9):1687-99. PubMed ID: 18840375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
    Moore WV; Dana K; Frane J; Lippe B
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant growth hormone for idiopathic short stature in children and adolescents.
    Bryant J; Cave C; Milne R
    Cochrane Database Syst Rev; 2003; (4):CD004440. PubMed ID: 14584015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.
    Wit JM; Rekers-Mombarg LT; Cutler GB; Crowe B; Beck TJ; Roberts K; Gill A; Chaussain JL; Frisch H; Yturriaga R; Attanasio AF
    J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human growth hormone treatment of short-stature children born small for gestational age: effect on muscle and adipose tissue mass during a 3-year treatment period and after 1 year's withdrawal.
    Leger J; Garel C; Fjellestad-Paulsen A; Hassan M; Czernichow P
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3512-6. PubMed ID: 9768656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study.
    Romer T; Saenger P; Peter F; Walczak M; Le Bouc Y; Khan-Boluki J; Berghout A
    Horm Res; 2009; 72(6):359-69. PubMed ID: 19844125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
    Kriström B; Aronson AS; Dahlgren J; Gustafsson J; Halldin M; Ivarsson SA; Nilsson NO; Svensson J; Tuvemo T; Albertsson-Wikland K
    J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human growth hormone for children born small for gestational age: meta-analysis confirms the consistent dose-effect relationship on catch-up growth.
    Crabbé R; von Holtey M; Engrand P; Chatelain P
    J Endocrinol Invest; 2008 Apr; 31(4):346-51. PubMed ID: 18475054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The short-term effects of growth hormone therapy on height velocity and cardiac ventricular wall thickness in children with Noonan's syndrome.
    Cotterill AM; McKenna WJ; Brady AF; Sharland M; Elsawi M; Yamada M; Camacho-Hübner C; Kelnar CJ; Dunger DB; Patton MA; Savage MO
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2291-7. PubMed ID: 8964866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 4-Year, Open-Label, Multicenter, Randomized Trial of Genotropin® Growth Hormone in Patients with Idiopathic Short Stature: Analysis of 4-Year Data Comparing Efficacy, Efficiency, and Safety between an Individualized, Target-Driven Regimen and Standard Dosing.
    Counts DR; Silverman LA; Rajicic N; Geffner ME; Newfield RS; Thornton P; Carakushansky M; Escobar O; Rapaport R; Levitsky L; Rotenstein D; Hey-Hadavi J; Wajnrajch MP
    Horm Res Paediatr; 2015; 84(2):79-87. PubMed ID: 25966824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of growth hormone dosing in children born small for gestational age: an open-label, randomized study of children during the fourth year of therapy.
    Chatelain P; Colle M; Nako JP; Le Luyer B; Wagner K; Berlier P; Tauber M
    Horm Res Paediatr; 2012; 77(3):156-63. PubMed ID: 22508151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of growth failure with growth hormone in children with chronic kidney disease: an open-label long-term study.
    Müller-Wiefel D; Frisch H; Tulassay T; Bell L; Zadik Z
    Clin Nephrol; 2010 Aug; 74(2):97-105. PubMed ID: 20630129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.